Aspen Pharmacare Holdings Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was ZAR 21,141 million compared to ZAR 19,150 million a year ago. Net income was ZAR 2,314 million compared to ZAR 2,674 million a year ago.

Basic earnings per share from continuing operations was ZAR 5.208 compared to ZAR 6.02 a year ago. Diluted earnings per share from continuing operations was ZAR 5.208 compared to ZAR 6.02 a year ago.